| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 23, 2025
London office expansion underlines Medtronic’s commitment to fostering cross-industry collaboration, contributing to ambitions of the NHS 10-Year Health Plan and driving surgical innovation.
-
Sep 22, 2025
The pivotal Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial demonstrates global clinical effectiveness, long-term safety, and patient preference
-
Sep 16, 2025
After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.
-
Sep 2, 2025
Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System
-
Sep 2, 2025
The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients
-
Aug 28, 2025
Indication demonstrates Medtronic’s commitment to innovative patient-centered solutions shaping the future of TAVR
